Home The Word Brain My Amedeo FAQ Privacy About   

2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Free Subscription

Articles published in Gut

Retrieve available abstracts of 103 articles:
HTML format

Single Articles

    May 2024
  1. BERKE G, Sahin-Toth M
    Intron-mediated enhancement of SPINK1 expression for pancreatitis therapy.
    Gut. 2024 May 16:gutjnl-2024-332818. doi: 10.1136/gutjnl-2024-332818.

  2. LOPEZ-GIL JC, Garcia-Silva S, Ruiz-Canas L, Navarro D, et al
    The Peptidoglycan Recognition Protein 1 confers immune evasive properties on pancreatic cancer stem cells.
    Gut. 2024 May 16:gutjnl-2023-330995. doi: 10.1136/gutjnl-2023-330995.
    PubMed     Abstract available

    April 2024
  3. THORNTON CS, Waddell BJ, Congly SE, Svishchuk J, et al
    Porcine-derived pancreatic enzyme replacement therapy may be linked to chronic hepatitis E virus infection in cystic fibrosis lung transplant recipients.
    Gut. 2024 Apr 15:gutjnl-2023-330602. doi: 10.1136/gutjnl-2023-330602.
    PubMed     Abstract available

  4. Correction: Identification of c-FLIPL and c-FLIPS as critical regulators of death receptor-induced apoptosis in pancreatic cancer cells.
    Gut. 2024;73:e8.

    March 2024
  5. WANG YC, Mao XT, Sun C, Wang YH, et al
    Pancreas-directed AAV8-hSPINK1 gene therapy safely and effectively protects against pancreatitis in mice.
    Gut. 2024 Mar 29:gutjnl-2023-330788. doi: 10.1136/gutjnl-2023-330788.
    PubMed     Abstract available

  6. GUNJAN D, Mahapatra SJ, Garg PK
    Is acute necrotising pancreatitis a chronic disease?
    Gut. 2024 Mar 26:gutjnl-2024-331915. doi: 10.1136/gutjnl-2024-331915.

    Response to: short-chain fatty acids in patients with severe acute pancreatitis: friend or foe?
    Gut. 2024 Mar 7:gutjnl-2024-332236. doi: 10.1136/gutjnl-2024-332236.

  8. PUST MM, Rocha Castellanos DM, Rzasa K, Dame A, et al
    Absence of a pancreatic microbiome in intraductal papillary mucinous neoplasm.
    Gut. 2024 Mar 1:gutjnl-2023-331012. doi: 10.1136/gutjnl-2023-331012.
    PubMed     Abstract available

    February 2024
  9. VAN DEN BERG FF, Besselink MG, van Santvoort H
    Short-chain fatty acids in patients with severe acute pancreatitis: friend or foe?
    Gut. 2024 Feb 15:gutjnl-2024-332129. doi: 10.1136/gutjnl-2024-332129.

    January 2024
  10. HOLLEMANS RA, Timmerhuis HC, Besselink MG, Bouwense SAW, et al
    Long-term follow-up study of necrotising pancreatitis: interventions, complications and quality of life.
    Gut. 2024 Jan 24:gutjnl-2023-329735. doi: 10.1136/gutjnl-2023-329735.
    PubMed     Abstract available

  11. TONELLI C, Yordanov GN, Hao Y, Deschenes A, et al
    A mucus production programme promotes classical pancreatic ductal adenocarcinoma.
    Gut. 2024 Jan 23:gutjnl-2023-329839. doi: 10.1136/gutjnl-2023-329839.
    PubMed     Abstract available

  12. SABA E, Farhat M, Daoud A, Khashan A, et al
    Oral bacteria accelerate pancreatic cancer development in mice.
    Gut. 2024 Jan 17:gutjnl-2023-330941. doi: 10.1136/gutjnl-2023-330941.
    PubMed     Abstract available

  13. KWAN MC, Pitman MB, Fernandez-Del Castillo C, Zhang ML, et al
    Revisiting the performance of cyst fluid carcinoembryonic antigen as a diagnostic marker for pancreatic mucinous cysts: a comprehensive 20-year institutional review.
    Gut. 2024 Jan 9:gutjnl-2023-331138. doi: 10.1136/gutjnl-2023-331138.
    PubMed     Abstract available

    December 2023
  14. AMMER-HERRMENAU C, Antweiler KL, Asendorf T, Beyer G, et al
    Gut microbiota predicts severity and reveals novel metabolic signatures in acute pancreatitis.
    Gut. 2023 Dec 21:gutjnl-2023-330987. doi: 10.1136/gutjnl-2023-330987.
    PubMed     Abstract available

  15. BEN-AMI R, Wang QL, Zhang J, Supplee JG, et al
    Protein biomarkers and alternatively methylated cell-free DNA detect early stage pancreatic cancer.
    Gut. 2023 Dec 13:gutjnl-2023-331074. doi: 10.1136/gutjnl-2023-331074.
    PubMed     Abstract available

  16. HANNEMANN A, Mayerle J, Beyer G
    Response to: Correspondence on 'Definition of age-dependent reference values for the diameter of the common bile duct and pancreatic duct on MRCP: still needed further discussion' by Wang et al.
    Gut. 2023 Dec 2:gutjnl-2023-331525. doi: 10.1136/gutjnl-2023-331525.

    October 2023
  17. SANDOR M, Sahin-Toth M
    Functional predictors of pathogenicity of missense CPA1 variants in chronic pancreatitis.
    Gut. 2023 Oct 19:gutjnl-2023-331105. doi: 10.1136/gutjnl-2023-331105.

  18. WANG F, Peng L, Liu Y
    Definition of age-dependent reference values for the diameter of the common bile duct and pancreatic duct on MRCP: still needed further discussion.
    Gut. 2023 Oct 10:gutjnl-2023-331163. doi: 10.1136/gutjnl-2023-331163.

  19. MICHL P, Roth L
    Female advantage in neoadjuvant pancreatic cancer therapy: is it down to macrophages?
    Gut. 2023 Oct 9:gutjnl-2023-330830. doi: 10.1136/gutjnl-2023-330830.

    September 2023
  20. VAN EIJCK CWF, Mustafa DAM, Vadgama D, de Miranda NFCC, et al
    Enhanced antitumour immunity following neoadjuvant chemoradiotherapy mediates a favourable prognosis in women with resected pancreatic cancer.
    Gut. 2023 Sep 14:gutjnl-2023-330480. doi: 10.1136/gutjnl-2023-330480.
    PubMed     Abstract available

  21. WU Y, Seufert I, Al-Shaheri FN, Kurilov R, et al
    DNA-methylation signature accurately differentiates pancreatic cancer from chronic pancreatitis in tissue and plasma.
    Gut. 2023 Sep 14:gutjnl-2023-330155. doi: 10.1136/gutjnl-2023-330155.
    PubMed     Abstract available

  22. KARSTENSEN JG, Novovic S, Schmidt PN
    Tailoring treatment to the circumstance: reasoning behind metal versus plastic drainage of pancreatic collections - authors' reply.
    Gut. 2023 Sep 12:gutjnl-2023-330948. doi: 10.1136/gutjnl-2023-330948.

    August 2023
  23. LIU X, Tang R, Xu J, Tan Z, et al
    CRIP1 fosters MDSC trafficking and resets tumour microenvironment via facilitating NF-kappaB/p65 nuclear translocation in pancreatic ductal adenocarcinoma.
    Gut. 2023 Aug 4:gutjnl-2022-329349. doi: 10.1136/gutjnl-2022-329349.
    PubMed     Abstract available

    July 2023
  24. VANELLA G, Bronswijk M, Van der Merwe SW, Arcidiacono PG, et al
    Tailoring treatment to the circumstance: reasoning behind metal versus plastic drainage of pancreatic collections.
    Gut. 2023 Jul 31:gutjnl-2023-330442. doi: 10.1136/gutjnl-2023-330442.

    June 2023
  25. BLANCO-GOMEZ A, Jorgensen C
    FAK scaffolds immune escape in pancreatic cancer.
    Gut. 2023 Jun 6:gutjnl-2023-330049. doi: 10.1136/gutjnl-2023-330049.

  26. SAMANTA J, Dhar J
    Plastic is as good as metal: is the 'debris clearance' debate for walled-off necrosis drainage finally over?
    Gut. 2023;72:1223-1224.

    May 2023
  27. KINKER GS, Vitiello GAF, Diniz AB, Cabral-Piccin MP, et al
    Mature tertiary lymphoid structures are key niches of tumour-specific immune responses in pancreatic ductal adenocarcinomas.
    Gut. 2023 May 25:gutjnl-2022-328697. doi: 10.1136/gutjnl-2022-328697.
    PubMed     Abstract available

    April 2023
  28. ZORNIAK M, Sirtl S, Beyer G, Mahajan UM, et al
    Consensus definition of sludge and microlithiasis as a possible cause of pancreatitis.
    Gut. 2023 Apr 18:gutjnl-2022-327955. doi: 10.1136/gutjnl-2022-327955.
    PubMed     Abstract available

  29. BANG JY, Jhala N, Seth A, Krall K, et al
    Standardisation of EUS-guided FNB technique for molecular profiling in pancreatic cancer: results of a randomised trial.
    Gut. 2023 Apr 11:gutjnl-2023-329495. doi: 10.1136/gutjnl-2023-329495.

  30. RAPETTI-MAUSS R, Nigri J, Berenguier C, Finetti P, et al
    SK2 channels set a signalling hub bolstering CAF-triggered tumourigenic processes in pancreatic cancer.
    Gut. 2023;72:722-735.
    PubMed     Abstract available

    March 2023
  31. CANEL M, Slawinska AD, Lonergan DW, Kallor AA, et al
    FAK suppresses antigen processing and presentation to promote immune evasion in pancreatic cancer.
    Gut. 2023 Mar 28:gutjnl-2022-327927. doi: 10.1136/gutjnl-2022-327927.
    PubMed     Abstract available

  32. HAMDAN FH, Abdelrahman AM, Kutschat AP, Wang X, et al
    Interactive enhancer hubs (iHUBs) mediate transcriptional reprogramming and adaptive resistance in pancreatic cancer.
    Gut. 2023 Mar 8:gutjnl-2022-328154. doi: 10.1136/gutjnl-2022-328154.
    PubMed     Abstract available

    February 2023
  33. HALLENSLEBEN ND, Stassen PMC, Schepers NJ, Besselink MG, et al
    Patient selection for urgent endoscopic retrograde cholangio-pancreatography by endoscopic ultrasound in predicted severe acute biliary pancreatitis (APEC-2): a multicentre prospective study.
    Gut. 2023 Feb 27:gutjnl-2022-328258. doi: 10.1136/gutjnl-2022-328258.
    PubMed     Abstract available

  34. LIU J, Bai W, Zhou T, Xie Y, et al
    SDCBP promotes pancreatic cancer progression by preventing YAP1 from beta-TrCP-mediated proteasomal degradation.
    Gut. 2023 Feb 24:gutjnl-2022-327492. doi: 10.1136/gutjnl-2022-327492.
    PubMed     Abstract available

  35. BEYER G, Kasprowicz F, Hannemann A, Aghdassi A, et al
    Definition of age-dependent reference values for the diameter of the common bile duct and pancreatic duct on MRCP: a population-based, cross-sectional cohort study.
    Gut. 2023 Feb 24:gutjnl-2021-326106. doi: 10.1136/gutjnl-2021-326106.
    PubMed     Abstract available

  36. KARAMITOPOULOU E, Wenning AS, Acharjee A, Zlobec I, et al
    Spatially restricted tumour-associated and host-associated immune drivers correlate with the recurrence sites of pancreatic cancer.
    Gut. 2023 Feb 15:gutjnl-2022-329371. doi: 10.1136/gutjnl-2022-329371.
    PubMed     Abstract available

    January 2023
  37. ZHU G, Wilhelm SJ, George LG, Cassidy BM, et al
    Preclinical mouse model of a misfolded PNLIP variant develops chronic pancreatitis.
    Gut. 2023 Jan 11:gutjnl-2022-327960. doi: 10.1136/gutjnl-2022-327960.
    PubMed     Abstract available

  38. GLAUBITZ J, Wilden A, Frost F, Ameling S, et al
    Activated regulatory T-cells promote duodenal bacterial translocation into necrotic areas in severe acute pancreatitis.
    Gut. 2023 Jan 11:gutjnl-2022-327448. doi: 10.1136/gutjnl-2022-327448.
    PubMed     Abstract available

  39. LOU H, Xie B, Wang Y, Gao Y, et al
    Improved NGS variant calling tool for the PRSS1-PRSS2 locus.
    Gut. 2023;72:210-212.

    November 2022
  40. KARSTENSEN JG, Novovic S, Hansen EF, Jensen AB, et al
    EUS-guided drainage of large walled-off pancreatic necroses using plastic versus lumen-apposing metal stents: a single-centre randomised controlled trial.
    Gut. 2022 Nov 29:gutjnl-2022-328225. doi: 10.1136/gutjnl-2022-328225.
    PubMed     Abstract available

    October 2022
  41. BOXHOORN L, Verdonk RC, Voermans RP
    Response to letter to the editor: lumen-apposing metal stents versus double-pigtail plastic stents for infected necrotising pancreatitis.
    Gut. 2022 Oct 13. pii: gutjnl-2022-328686. doi: 10.1136/gutjnl-2022-328686.

    September 2022
  42. DE ANDRES MP, Jackson RJ, Felipe I, Zagorac S, et al
    GATA4 and GATA6 loss-of-expression is associated with extinction of the classical programme and poor outcome in pancreatic ductal adenocarcinoma.
    Gut. 2022 Sep 15. pii: gutjnl-2021-325803. doi: 10.1136/gutjnl-2021-325803.
    PubMed     Abstract available

    August 2022
  43. TIWARI A, Shah A, Singh J
    LAMS versus plastic stents for infected pancreatic walled off necrosis (WON): has the addition of the TENSION trial to the AXIOMA study eased the tension?
    Gut. 2022 Aug 17. pii: gutjnl-2022-328148. doi: 10.1136/gutjnl-2022-328148.

  44. LIFFERS ST, Godfrey L, Frohn L, Haeberle L, et al
    Molecular heterogeneity and commonalities in pancreatic cancer precursors with gastric and intestinal phenotype.
    Gut. 2022 Aug 9. pii: gutjnl-2021-326550. doi: 10.1136/gutjnl-2021-326550.
    PubMed     Abstract available

    July 2022
  45. LARGHI A, Facciorusso A
    Lumen-apposing metal stents versus double-pigtail plastic stents for infected necrotising pancreatitis: more doubts than answers.
    Gut. 2022 Jul 1. pii: gutjnl-2022-328149. doi: 10.1136/gutjnl-2022-328149.

    June 2022
  46. TAN PS, Garriga C, Clift A, Liao W, et al
    Temporality of body mass index, blood tests, comorbidities and medication use as early markers for pancreatic ductal adenocarcinoma (PDAC): a nested case-control study.
    Gut. 2022 Jun 27. pii: gutjnl-2021-326522. doi: 10.1136/gutjnl-2021-326522.
    PubMed     Abstract available

  47. BOXHOORN L, Verdonk RC, Besselink MG, Boermeester M, et al
    Comparison of lumen-apposing metal stents versus double-pigtail plastic stents for infected necrotising pancreatitis.
    Gut. 2022 Jun 14. pii: gutjnl-2021-325632. doi: 10.1136/gutjnl-2021-325632.
    PubMed     Abstract available

  48. WANG L, Liu Y, Dai Y, Tang X, et al
    Single-cell RNA-seq analysis reveals BHLHE40-driven pro-tumour neutrophils with hyperactivated glycolysis in pancreatic tumour microenvironment.
    Gut. 2022 Jun 10. pii: gutjnl-2021-326070. doi: 10.1136/gutjnl-2021-326070.
    PubMed     Abstract available

    May 2022
  49. DE SANTIS MC, Gozzelino L, Margaria JP, Costamagna A, et al
    Lysosomal lipid switch sensitises to nutrient deprivation and mTOR targeting in pancreatic cancer.
    Gut. 2022 May 27. pii: gutjnl-2021-325117. doi: 10.1136/gutjnl-2021-325117.
    PubMed     Abstract available

  50. JANCSO Z, Demcsak A, Sahin-Toth M
    Modelling chronic pancreatitis as a complex genetic disease in mice.
    Gut. 2022 May 16. pii: gutjnl-2022-327601. doi: 10.1136/gutjnl-2022-327601.

  51. ALFARANO G, Audano M, Di Chiaro P, Balestrieri C, et al
    Interferon regulatory factor 1 (IRF1) controls the metabolic programmes of low-grade pancreatic cancer cells.
    Gut. 2022 May 13. pii: gutjnl-2021-325811. doi: 10.1136/gutjnl-2021-325811.
    PubMed     Abstract available

    April 2022
  52. YANG X, Yao L, Dai L, Yuan M, et al
    Alcohol predisposes obese mice to acute pancreatitis via adipose triglyceride lipase-dependent visceral adipocyte lipolysis.
    Gut. 2022 Apr 22. pii: gutjnl-2022-326958. doi: 10.1136/gutjnl-2022-326958.

  53. ALONSO-NOCELO M, Ruiz-Canas L, Sancho P, Gorgulu K, et al
    Macrophages direct cancer cells through a LOXL2-mediated metastatic cascade in pancreatic ductal adenocarcinoma.
    Gut. 2022 Apr 15. pii: gutjnl-2021-325564. doi: 10.1136/gutjnl-2021-325564.
    PubMed     Abstract available

  54. COFFELT SB, Morton JP
    LOXL2 in pancreatic tumourigenesis: the complexity of tumour-stromal crosstalk exemplified.
    Gut. 2022 Apr 15. pii: gutjnl-2022-327430. doi: 10.1136/gutjnl-2022-327430.

  55. Correction: Localisation of PGK1 determines metabolic phenotype to balance metastasis and proliferation in patients with SMAD4-negative pancreatic cancer.
    Gut. 2022;71:e5.

    March 2022
  56. KARTAL E, Schmidt TSB, Molina-Montes E, Rodriguez-Perales S, et al
    A faecal microbiota signature with high specificity for pancreatic cancer.
    Gut. 2022 Mar 8. pii: gutjnl-2021-324755. doi: 10.1136/gutjnl-2021-324755.
    PubMed     Abstract available

  57. NEWSOME R, Jobin C
    Finding clues in unexpected places: detection of pancreatic cancer through the faecal microbiome.
    Gut. 2022 Mar 8. pii: gutjnl-2021-326710. doi: 10.1136/gutjnl-2021-326710.

  58. HE Z, Zhao S, Wang S, Song S, et al
    Rare cause of recurrent acute pancreatitis: a double whammy from the pancreas and duodenum.
    Gut. 2022 Mar 4. pii: gutjnl-2021-326704. doi: 10.1136/gutjnl-2021-326704.

    February 2022
  59. NAYAR M, Leeds JS, Oppong K
    Lumen-apposing metal stents for drainage of pancreatic fluid collections: does timing of removal matter?
    Gut. 2022 Feb 25. pii: gutjnl-2021-325812. doi: 10.1136/gutjnl-2021-325812.

  60. AMATO A, Tarantino I, Facciorusso A, Binda C, et al
    Real-life multicentre study of lumen-apposing metal stent for EUS-guided drainage of pancreatic fluid collections.
    Gut. 2022 Feb 22. pii: gutjnl-2022-326880. doi: 10.1136/gutjnl-2022-326880.

    January 2022
  61. KUMAR S, Schoonderwoerd MJA, Kroonen JS, de Graaf IJ, et al
    Targeting pancreatic cancer by TAK-981: a SUMOylation inhibitor that activates the immune system and blocks cancer cell cycle progression in a preclinical model.
    Gut. 2022 Jan 24. pii: gutjnl-2021-324834. doi: 10.1136/gutjnl-2021-324834.
    PubMed     Abstract available

  62. VARGHESE C, Nayar M, Pandanaboyana S
    SARS-CoV-2 pandemic has impacted on patterns of aetiology for acute pancreatitis and management of gallstone pancreatitis in the UK.
    Gut. 2022 Jan 17. pii: gutjnl-2021-326845. doi: 10.1136/gutjnl-2021-326845.

  63. BELLOMO G, Rainer C, Quaranta V, Astuti Y, et al
    Chemotherapy-induced infiltration of neutrophils promotes pancreatic cancer metastasis via Gas6/AXL signalling axis.
    Gut. 2022 Jan 12. pii: gutjnl-2021-325272. doi: 10.1136/gutjnl-2021-325272.
    PubMed     Abstract available

  64. RUIVO CF, Bastos N, Adem B, Batista I, et al
    Extracellular Vesicles from Pancreatic Cancer Stem Cells Lead an Intratumor Communication Network (EVNet) to fuel tumour progression.
    Gut. 2022 Jan 10. pii: gutjnl-2021-324994. doi: 10.1136/gutjnl-2021-324994.
    PubMed     Abstract available

  65. WANG YC, Mao XT, Yu D, Mao SH, et al
    Alcohol amplifies the association between common variants at PRSS1-PRSS2 locus and chronic pancreatitis in a dose-dependent manner.
    Gut. 2022 Jan 7. pii: gutjnl-2021-326670. doi: 10.1136/gutjnl-2021-326670.

    December 2021
  66. HUANG HC, Sung YC, Li CP, Wan D, et al
    Reversal of pancreatic desmoplasia by a tumour stroma-targeted nitric oxide nanogel overcomes TRAIL resistance in pancreatic tumours.
    Gut. 2021 Dec 17. pii: gutjnl-2021-325180. doi: 10.1136/gutjnl-2021-325180.
    PubMed     Abstract available

    Understanding pain in chronic pancreatitis: not yet the end of the story?
    Gut. 2021 Dec 9. pii: gutjnl-2021-326279. doi: 10.1136/gutjnl-2021-326279.

    November 2021
  68. NAYAR M, Varghese C, Kanwar A, Siriwardena AK, et al
    SARS-CoV-2 infection is associated with an increased risk of idiopathic acute pancreatitis but not pancreatic exocrine insufficiency or diabetes: long-term results of the COVIDPAN study.
    Gut. 2021 Nov 11. pii: gutjnl-2021-326218. doi: 10.1136/gutjnl-2021-326218.

  69. BENITZ S, Crawford H
    Discovery of the pancreatic basal cell: a new candidate for an adult stem cell emerges.
    Gut. 2021 Nov 3. pii: gutjnl-2021-325694. doi: 10.1136/gutjnl-2021-325694.

  70. EROSS B, Szentesi A, Hegyi P
    Metabolic signature might be an option to identify patients with early CP.
    Gut. 2021;70:2023-2024.

    October 2021
  71. LEE B, Namkoong H, Yang Y, Huang H, et al
    Single-cell sequencing unveils distinct immune microenvironments with CCR6-CCL20 crosstalk in human chronic pancreatitis.
    Gut. 2021 Oct 26. pii: gutjnl-2021-324546. doi: 10.1136/gutjnl-2021-324546.
    PubMed     Abstract available

  72. CABASAG CJ, Ferlay J, Laversanne M, Vignat J, et al
    Pancreatic cancer: an increasing global public health concern.
    Gut. 2021 Oct 22. pii: gutjnl-2021-326311. doi: 10.1136/gutjnl-2021-326311.

  73. OLESEN SS, Phillips AE, Faghih M, Kuhlmann L, et al
    Overlap and cumulative effects of pancreatic duct obstruction, abnormal pain processing and psychological distress on patient-reported outcomes in chronic pancreatitis.
    Gut. 2021 Oct 21. pii: gutjnl-2021-325855. doi: 10.1136/gutjnl-2021-325855.
    PubMed     Abstract available

  74. YANG F, Huang Y, Li T, Fu Y, et al
    Prevalence and outcomes of acute pancreatitis in COVID-19: a meta-analysis.
    Gut. 2021 Oct 20. pii: gutjnl-2021-325941. doi: 10.1136/gutjnl-2021-325941.

  75. KRYKLYVA V, Luchini C, Stommel MWJ, Nagtegaal ID, et al
    Detecting Lynch syndrome in pancreatic ductal adenocarcinoma FNA cytology based on cancer history and immunocytochemistry.
    Gut. 2021 Oct 19. pii: gutjnl-2021-326033. doi: 10.1136/gutjnl-2021-326033.

    July 2021
  76. MARTENS S, Coolens K, Van Bulck M, Arsenijevic T, et al
    Discovery and 3D imaging of a novel DeltaNp63-expressing basal cell type in human pancreatic ducts with implications in disease.
    Gut. 2021 Jul 30. pii: gutjnl-2020-322874. doi: 10.1136/gutjnl-2020-322874.
    PubMed     Abstract available

  77. HALLENSLEBEN ND, Timmerhuis HC, Hollemans RA, Pocornie S, et al
    Optimal timing of cholecystectomy after necrotising biliary pancreatitis.
    Gut. 2021 Jul 16. pii: gutjnl-2021-324239. doi: 10.1136/gutjnl-2021-324239.
    PubMed     Abstract available

    June 2021
    Pancreatic cancer surveillance and its ongoing challenges: is it time to refine our eligibility criteria?
    Gut. 2021 Jun 18. pii: gutjnl-2021-324739. doi: 10.1136/gutjnl-2021-324739.

  79. LV XH, Deng K, Yang JL
    Duality of the association between COVID-19 and acute pancreatitis.
    Gut. 2021 Jun 15. pii: gutjnl-2021-325221. doi: 10.1136/gutjnl-2021-325221.

    May 2021
  80. KOSCHNY R, Lang M, Hackert T
    Enormously dilated pancreatic duct.
    Gut. 2021 May 7. pii: gutjnl-2021-324335. doi: 10.1136/gutjnl-2021-324335.

  81. GENIN E, Cooper DN, Masson E, Ferec C, et al
    NGS mismapping confounds the clinical interpretation of the PRSS1 p.Ala16Val (c.47C>T) variant in chronic pancreatitis.
    Gut. 2021 May 7. pii: gutjnl-2021-324943. doi: 10.1136/gutjnl-2021-324943.

    April 2021
  82. CHANDRA V, McAllister F
    Therapeutic potential of microbial modulation in pancreatic cancer.
    Gut. 2021 Apr 27. pii: gutjnl-2019-319807. doi: 10.1136/gutjnl-2019-319807.

  83. HACKENG WM, Brosens LAA, Kim JY, O'Sullivan R, et al
    Non-functional pancreatic neuroendocrine tumours: ATRX/DAXX and alternative lengthening of telomeres (ALT) are prognostically independent from ARX/PDX1 expression and tumour size.
    Gut. 2021 Apr 13. pii: gutjnl-2020-322595. doi: 10.1136/gutjnl-2020-322595.
    PubMed     Abstract available

  84. KLOESCH B, Ionasz V, Paliwal S, Hruschka N, et al
    A GATA6-centred gene regulatory network involving HNFs and DeltaNp63 controls plasticity and immune escape in pancreatic cancer.
    Gut. 2021 Apr 12. pii: gutjnl-2020-321397. doi: 10.1136/gutjnl-2020-321397.
    PubMed     Abstract available

  85. XIE Z, Gao Y, Ho C, Li L, et al
    Exosome-delivered CD44v6/C1QBP complex drives pancreatic cancer liver metastasis by promoting fibrotic liver microenvironment.
    Gut. 2021 Apr 7. pii: gutjnl-2020-323014. doi: 10.1136/gutjnl-2020-323014.
    PubMed     Abstract available

  86. OVERBEEK KA, Levink IJM, Koopmann BDM, Harinck F, et al
    Long-term yield of pancreatic cancer surveillance in high-risk individuals.
    Gut. 2021 Apr 5. pii: gutjnl-2020-323611. doi: 10.1136/gutjnl-2020-323611.
    PubMed     Abstract available

    March 2021
  87. GLEESON FC, Jeraldo P, Levy MJ, Murphy SJ, et al
    Composition, diversity and potential utility of intervention-naive pancreatic cancer intratumoral microbiome signature profiling via endoscopic ultrasound.
    Gut. 2021 Mar 22. pii: gutjnl-2021-324031. doi: 10.1136/gutjnl-2021-324031.

  88. ZHOU T, Liu J, Xie Y, Yuan S, et al
    ESE3/EHF, a promising target of rosiglitazone, suppresses pancreatic cancer stemness by downregulating CXCR4.
    Gut. 2021 Mar 5. pii: gutjnl-2020-321952. doi: 10.1136/gutjnl-2020-321952.
    PubMed     Abstract available

  89. KOLODKIN-GAL D, Roitman L, Ovadya Y, Azazmeh N, et al
    Senolytic elimination of Cox2-expressing senescent cells inhibits the growth of premalignant pancreatic lesions.
    Gut. 2021 Mar 1. pii: gutjnl-2020-321112. doi: 10.1136/gutjnl-2020-321112.
    PubMed     Abstract available

    February 2021
  90. TACELLI M, Zaccari P, Capurso G, Arcidiacono PG, et al
    Artificial intelligence in EUS for autoimmune pancreatitis: bias and real life.
    Gut. 2021 Feb 22. pii: gutjnl-2021-324338. doi: 10.1136/gutjnl-2021-324338.

  91. SUN X, He X, Zhang Y, Hosaka K, et al
    Inflammatory cell-derived CXCL3 promotes pancreatic cancer metastasis through a novel myofibroblast-hijacked cancer escape mechanism.
    Gut. 2021 Feb 10. pii: gutjnl-2020-322744. doi: 10.1136/gutjnl-2020-322744.
    PubMed     Abstract available

  92. PANDANABOYANA S, Moir J, Leeds JS, Oppong K, et al
    SARS-CoV-2 infection in acute pancreatitis increases disease severity and 30-day mortality: COVID PAN collaborative study.
    Gut. 2021 Feb 5. pii: gutjnl-2020-323364. doi: 10.1136/gutjnl-2020-323364.
    PubMed     Abstract available

  93. ADAM MG, Beyer G, Christiansen N, Kamlage B, et al
    Identification and validation of a multivariable prediction model based on blood plasma and serum metabolomics for the distinction of chronic pancreatitis subjects from non-pancreas disease control subjects.
    Gut. 2021 Feb 4. pii: gutjnl-2020-320723. doi: 10.1136/gutjnl-2020-320723.
    PubMed     Abstract available

    January 2021
  94. LUCHINI C, Grant RC, Scarpa A, Gallinger S, et al
    Microsatellite instability/mismatch repair deficiency in pancreatic cancers: the same or different?
    Gut. 2021 Jan 19. pii: gutjnl-2020-323805. doi: 10.1136/gutjnl-2020-323805.

    November 2020
  95. RANA SS, Gupta R
    Walled of necrosis, disconnected pancreatic duct and metal stents: the debate continues!
    Gut. 2020 Nov 9. pii: gutjnl-2020-323190. doi: 10.1136/gutjnl-2020-323190.

  96. FROST F, Kacprowski T, Ruhlemann M, Pietzner M, et al
    Long-term instability of the intestinal microbiome is associated with metabolic liver disease, low microbiota diversity, diabetes mellitus and impaired exocrine pancreatic function.
    Gut. 2020 Nov 9. pii: gutjnl-2020-322753. doi: 10.1136/gutjnl-2020-322753.
    PubMed     Abstract available

  97. KEMPENEERS MA, Issa Y, Verdonk RC, Bruno M, et al
    Pain patterns in chronic pancreatitis: a nationwide longitudinal cohort study.
    Gut. 2020 Nov 6. pii: gutjnl-2020-322117. doi: 10.1136/gutjnl-2020-322117.
    PubMed     Abstract available

    October 2020
  98. SANO M, Takahashi R, Ijichi H, Ishigaki K, et al
    Blocking VCAM-1 inhibits pancreatic tumour progression and cancer-associated thrombosis/thromboembolism.
    Gut. 2020 Oct 21. pii: gutjnl-2020-320608. doi: 10.1136/gutjnl-2020-320608.
    PubMed     Abstract available

  99. MARYA NB, Powers PD, Chari ST, Gleeson FC, et al
    Utilisation of artificial intelligence for the development of an EUS-convolutional neural network model trained to enhance the diagnosis of autoimmune pancreatitis.
    Gut. 2020 Oct 7. pii: gutjnl-2020-322821. doi: 10.1136/gutjnl-2020-322821.
    PubMed     Abstract available

  100. DIAFERIA GR, Natoli G
    Transcription factors as drivers of distinct pancreatic ductal adenocarcinoma (PDAC) programmes: a role for HNF4A.
    Gut. 2020 Oct 1. pii: gutjnl-2020-322814. doi: 10.1136/gutjnl-2020-322814.

    September 2020
  101. WEISS FU, Laemmerhirt F, Lerch MM
    Next generation sequencing pitfalls in diagnosing trypsinogen (PRSS1) mutations in chronic pancreatitis.
    Gut. 2020 Sep 28. pii: gutjnl-2020-322864. doi: 10.1136/gutjnl-2020-322864.

  102. BARRETO SG, Habtezion A, Gukovskaya A, Lugea A, et al
    Critical thresholds: key to unlocking the door to the prevention and specific treatments for acute pancreatitis.
    Gut. 2020 Sep 24. pii: gutjnl-2020-322163. doi: 10.1136/gutjnl-2020-322163.
    PubMed     Abstract available

    April 2020
  103. HU Q, Wu J, Ren Y, Wu X, et al
    Degree of STING activation is associated with disease outcomes.
    Gut. 2020;69:792-794.

Thank you for your interest in scientific medicine.

AMEDEO Pancreatitis is free of charge.